CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Misonix, Inc. Company Snapshot
Misonix, Inc. operates within the Laboratory apparatus and furniture sector. In addition to historical fundamental analyses, the complete report available to purchase compares Misonix with three other laboratory equipment in North America: Cesca Therapeutics Inc (2016 sales of $11.93 million ), Combimatrix Corp ($12.87 million of which 100% was Oligonucleotide Array), and Profire Energy, Incorporation ($21.32 million of which 100% was Burners & heaters).

Sales Analysis. During the year ended June of 2016, sales at Misonix were $23.11 million. This is an increase of 4.1% versus 2015, when the company's sales were $22.20 million. This was the third consecutive year of growth at Misonix.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Misonix, Inc.
  Stock Performance Chart for Misonix, Inc.
 
  Stock Data: Recent Stock Performance:
  Current Price (5/19/2017): 10.15
(Figures in U.S. Dollars)
1 Week -4.2%   13 Weeks -7.7%  
4 Weeks 5.7%   52 Weeks 132.8%  
 
Misonix, Inc. Key Data:
  Ticker: MSON Country: United States
  Exchanges: NAS Major Industry: Capital Goods
    Sub Industry: Laboratory Apparatus & Furniture
  2016 Sales 23,113,194
(Year Ending Jan 2017).
Employees: 85
  Currency: U.S. Dollars Market Cap: 91,587,043
  Fiscal Yr Ends: June Shares Outstanding: 9,023,354
  Share Type: Common Closely Held Shares: 2,860,722
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.